Nephrol Dial Transplant (2002) 17: 1419-1425
© 2002 European Renal Association-European Dialysis and Transplant Association
Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency
Division of Nephrology, University of California at San Francisco, San Francisco, CA 94143, USA
Background. Reduced renal function is associated with a variety of biochemical abnormalities. However, the extent of these changes and their magnitude in relation to renal function is not well defined, especially among individuals with mild to moderate chronic renal insufficiency (CRI).
Methods. We analysed the Third National Health and Nutrition Examination Survey (NHANES III; 19881994) data for 14722 adults aged
17 years with measurements of serum creatinine and all electrolytes including ionized calcium. General linear models were used to determine the relationship between mean concentrations of electrolytes and different levels of CockcroftGault creatinine clearance (CrCl). Sample weights were used to produce weighted regression parameters.
Results. Changes in mean serum phosphorus and potassium concentration were evident at relatively modest reductions in CrCl (around 50 to 60 ml/min). Changes in the anion gap and mean levels of ionized calcium and bicarbonate were not apparent until CRI was advanced (CrCl
20 ml/min). For example, compared with women with CrCl >80 ml/min, those with CrCl 6050, 5040, 4030, 3020 and
20 ml/min had mean serum phosphorus concentrations that were higher by 0.1, 0.1, 0.2, 0.3 and 0.8 mg/dl (all P<0.05), and mean serum potassium concentrations that were higher by 0.1, 0.1, 0.1, 0.2 and 0.4 mmol/l (all P<0.05), respectively. These changes were independent of dietary intake and the use of angiotensin converting enzyme (ACE) inhibitors or non-steroidal anti-inflammatory drugs (NSAIDs).
Conclusions. Increases in serum phosphorus and potassium levels are apparent even among people with mild to moderate CRI. These findings should be broadly generalizable to the larger CRI population in the United States. Subtle elevations in serum phosphorus might contribute to the initiation and maintenance of secondary hyperparathyroidism, which is known to occur in mild to moderate CRI.
Keywords: chronic renal insufficiency; phosphorous; potassium
Correspondence and offprint requests to: Chi-yuan Hsu, Division of Nephrology, University of California, San Francisco, Room 672 HSE, 513 Parnassus Avenue, San Francisco, CA 94143-0532, USA. Email: hsuchi{at}medicine.ucsf.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. A. Frassetto and C.-y. Hsu Metabolic Acidosis and Progression of Chronic Kidney Disease J. Am. Soc. Nephrol., September 1, 2009; 20(9): 1869 - 1870. [Full Text] [PDF] |
||||
![]() |
P. Muntner, T. M. Jones, A. D. Hyre, M. L. Melamed, A. Alper, P. Raggi, and M. B. Leonard Association of Serum Intact Parathyroid Hormone with Lower Estimated Glomerular Filtration Rate Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 186 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Moranne, M. Froissart, J. Rossert, C. Gauci, J.-J. Boffa, J. P. Haymann, M. B. M'rad, C. Jacquot, P. Houillier, B. Stengel, et al. Timing of Onset of CKD-Related Metabolic Complications J. Am. Soc. Nephrol., January 1, 2009; 20(1): 164 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Voormolen, M. Noordzij, D. C. Grootendorst, I. Beetz, Y. W. Sijpkens, J. G. van Manen, E. W. Boeschoten, R. M. Huisman, R. T. Krediet, F. W. Dekker, et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2909 - 2916. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Taylor, J. P. Forman, and W. R. Farwell Serum Anion Gap and Blood Pressure in the National Health and Nutrition Examination Survey Hypertension, August 1, 2007; 50(2): 320 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thanamayooran, C. Rose, and D. J. Hirsch Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2385 - 2393. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli, F. Sacks, M. Pfeffer, Z. Gao, G. Curhan, and for the Cholesterol And Recurrent Events (CARE) Tr Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease Circulation, October 25, 2005; 112(17): 2627 - 2633. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Chertow and S. M. Moe Calcification or Classification? J. Am. Soc. Nephrol., February 1, 2005; 16(2): 293 - 295. [Full Text] [PDF] |
||||
![]() |
G. M. Chertow A 43-Year-Old Woman With Chronic Renal Insufficiency JAMA, March 10, 2004; 291(10): 1252 - 1259. [Full Text] [PDF] |
||||





